For a child with congenital anomalies not compatible with life, who should be involved in the decision to implement a Do Not Resuscitate (DNR) order?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DNR Decision-Making in Pediatric Patients with Congenital Anomalies Incompatible with Life

Parents should be involved in the DNR decision through a shared decision-making process with the medical team, rather than requiring approval from three providers. 1

The Correct Approach: Shared Decision-Making with Family

The American Academy of Pediatrics explicitly states that parents and family caregivers are recognized as best able to appreciate the best interests of the child and should be fully involved in decision-making about forgoing life-sustaining medical treatment, including DNR orders. 1 This represents the central ethical framework for pediatric end-of-life decisions.

Key Elements of the Decision Process:

  • The treating physician writes the DNR order after documented discussion with parents/family, not after approval by three separate physicians. 1, 2

  • Parents serve as surrogate decision-makers and have rights to make decisions about resuscitation, though these rights are limited by the infant's best interests. 3

  • The physician must document the rationale for the DNR order, prognosis, content of discussions with family and medical team, expressed wishes of family decision-makers, and any unresolved issues. 1

When Multiple Providers Should Be Involved

While three physicians are not required to approve a DNR order, interdisciplinary consultation is strongly recommended in complex cases:

  • Consultation with palliative care specialists can promote effective communication and support for families. 1

  • Ethics consultation services should be utilized when conflicts arise between the care team and family, or when the care team is strongly divided about treatment options. 1

  • Multiple pediatric subspecialists may contribute guidance when caring for children with medical complexity, but this is for clinical input, not formal approval. 1

Special Considerations for Congenital Anomalies Incompatible with Life

For newborns with life-threatening congenital anomalies where prognosis is uncertain but likely very poor, the AAP recognizes that:

  • Resuscitation may not be indicated when congenital anomalies are associated with almost certain early death and unacceptably high morbidity among rare survivors. 1

  • Shared decision-making with the family is supported for conditions with uncertain prognosis where survival is borderline. 1

  • The same ethical principles apply as for other children: interventions may be withheld when there is consensus they do not provide net benefit and fail to support the child's best interests. 1

Common Pitfalls to Avoid

  • Do not assume unilateral physician decision-making is standard: While some states legally permit physicians to write unilateral DNAR orders in rare circumstances, this should only occur after exhaustive conflict resolution attempts and ethics consultation. 1, 4

  • Do not confuse DNR with withdrawal of all care: DNR orders specifically address cardiopulmonary resuscitation only and do not automatically limit other medical interventions unless explicitly stated. 1, 2

  • Do not use oral DNR orders: A licensed physician must write the order in the medical record with full documentation. 1, 2

Documentation Requirements

The written DNR order must include:

  • Clear statement of which interventions are withheld (chest compressions, defibrillation, etc.). 2
  • Explicit instructions about which interventions continue (comfort measures, oxygen, pain management, etc.). 2
  • Date of implementation and signatures of physician and family/surrogate. 2
  • Plan for periodic review, especially if the patient's condition changes. 5, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Essential Components of DNR/DNI Consent Forms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Parental rights at the birth of a near-viable infant: conflicting perspectives.

American journal of obstetrics and gynecology, 1997

Guideline

DNR Order Management in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What should a provider do if a 15-month-old pediatric patient with a Do Not Resuscitate (DNR) order from another facility presents for treatment?
What is the immediate course of action if a Do Not Resuscitate (DNR) order is discovered after treatment has begun for a 15-month-old pediatric patient in the Emergency Room (ER)?
What is the recommended frequency for reviewing a Do Not Resuscitate (DNR) order for a child with a severe neurological progressive condition?
What is the most appropriate immediate action for a neonate who has been coded blue and has an incomplete 'do not resuscitate' (DNR) discussion with the parents?
What is the management for a patient with enteritis caused by Henoch-Schonlein purpura (HSP)?
What are the typical clinical presentation and physical exam findings in a middle-aged adult with a ruptured Baker cyst and a history of knee problems, including potential arthritis?
How should fluids and blood products be managed in the operating room for a patient undergoing major surgery with anticipated significant blood loss and potential underlying medical conditions?
What is the recommended treatment for a patient with seasonal asthma?
What is the optimal treatment approach for a patient with severe eosinophilic asthma, considering their current regimen of inhaled corticosteroids (ICS) and potential need for additional therapies such as anti-interleukin-5 (IL-5) medications like mepolizumab (mepolizumab), benralizumab (benralizumab), or reslizumab (reslizumab)?
What is the recommended treatment approach for a patient with Long Covid (Post-Acute Sequelae of SARS-CoV-2 infection), considering their individual symptoms and medical history?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.